{"gene":"METTL8","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2021,"finding":"METTL8 is a mitochondrial protein that installs 3-methylcytidine (m3C) at position C32 of mt-tRNASer(UCN) and mt-tRNAThr. METTL8 knockout reduces respiratory chain activity while overexpression increases it. Mitoribosome profiling revealed stalling on mt-tRNASer(UCN)- and mt-tRNAThr-dependent codons in knockout cells, and mass spectrometry showed reduced incorporation of ND6 and ND1 into complex I.","method":"Knockout/overexpression cell lines, mitochondrial ribosome profiling, mass spectrometry of respiratory chain complexes, m3C detection","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (ribosome profiling, MS, KO/OE phenotypes), replicated across multiple subsequent studies","pmids":["34774131"],"is_preprint":false},{"year":2022,"finding":"METTL8 exists as alternatively spliced isoforms: METTL8-Iso1 is targeted to mitochondria via an N-terminal pre-sequence and catalyzes m3C32 on mt-tRNAThr and mt-tRNASer(UCN), while METTL8-Iso4 localizes to the nucleolus. Substrate specificity of Iso1 for mt-tRNAThr requires G35 but not t6A37, while mt-tRNASer(UCN) modification critically depends on i6A37. METTL8-Iso1 interacts with mitochondrial seryl-tRNA synthetase (SARS2) in an RNA-independent manner, which modestly accelerates m3C modification activity.","method":"Alternative splicing analysis, subcellular fractionation/localization, in vitro methylation assays, mutagenesis of tRNA recognition elements, Co-IP","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis, isoform localization experiments, RNA-independent Co-IP, replicated by multiple labs","pmids":["35357504"],"is_preprint":false},{"year":2022,"finding":"METTL8 is a mitochondria-associated protein required for m3C formation in human mt-tRNA-Ser-UGA and mt-tRNA-Thr-UGU but not nuclear-encoded tRNAs. METTL8 interacts with mitochondrial seryl-tRNA synthetase and mt-tRNAs. Re-expression of WT METTL8 rescues m3C loss, but a variant lacking the N-terminal mitochondrial localization signal does not. Loss of METTL8 alters native migration pattern of mt-tRNA-Ser-UGA, suggesting m3C influences tRNA folding.","method":"METTL8-deficient human cells, m3C detection by sequencing, Co-IP with mitochondrial seryl-tRNA synthetase, rescue with MLS-deletion variant, native gel analysis of tRNA migration","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (KO rescue, Co-IP, tRNA migration assay), consistent with replicated findings across labs","pmids":["35247384"],"is_preprint":false},{"year":2022,"finding":"METTL8 crosslinks to the anticodon stem loop (ASL) of many mt-tRNAs, but methylation target specificity is determined by U34G35 combined with t6A37/(ms2)i6A37, present only in mt-tRNAThr and mt-tRNASer(UCN). m3C32 modification influences the structure of these mt-tRNAs, though mt-tRNAs lacking m3C32 are still efficiently aminoacylated and associate with mitochondrial ribosomes. Mitochondrial translation is mildly impaired without METTL8.","method":"METTL8 crosslinking to mt-tRNAs, dissection of tRNA recognition elements by mutagenesis, structural probing of mt-tRNAs, aminoacylation assays, mitoribosome association assays, translation assays in METTL8 KO cells","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods including crosslinking, in vitro mutagenesis of recognition elements, structural and functional assays","pmids":["35017528"],"is_preprint":false},{"year":2023,"finding":"Mettl8-Iso4 (nucleolar isoform) is catalytically inactive for m3C32 generation due to lack of the N-terminal extension (N-extension), which contains absolutely conserved modification-critical residues. These residues are also essential for cytoplasmic m3C32 by METTL2A and yeast Trm140. METTL8-Iso1 can modify several cytoplasmic or bacterial tRNAs in vitro. METTL8-Iso1 also interacts with mitochondrial threonyl-tRNA synthetase (TARS2) in addition to SARS2, and substantially stimulates aminoacylation activities of both SARS2 and TARS2 in vitro.","method":"In vitro m3C32 methylation assays with Iso1 and Iso4, mutagenesis of N-extension residues, cross-species tRNA modification assays, Co-IP with TARS2, aminoacylation activity assays","journal":"Science bulletin","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis, cross-species tRNA assays, aminoacylation functional assays","pmids":["37573249"],"is_preprint":false},{"year":2020,"finding":"METTL8 forms a large SUMOylated nuclear RNA-binding protein complex (~0.8 megadaltons) containing R-loop-related factors in the nucleus. Genetic ablation of METTL8 results in overall reduction of R-loops in cells. METTL8 binds to RNAs and stabilizes R-loops on selected gene regions through its methyltransferase activity on m3C.","method":"Biochemical fractionation, pulldown/interaction assays, R-loop quantification after METTL8 knockout, RNA-binding assays","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and genetic KO with R-loop readout, single lab, two orthogonal methods","pmids":["32199293"],"is_preprint":false},{"year":2018,"finding":"METTL8 is a STAT3 transcriptional target in mouse ESCs. METTL8 interacts with Mapkbp1 mRNA (an intermediate in JNK signaling) and inhibits translation of that mRNA, thereby suppressing JNK pathway activation and enhancing ESC differentiation.","method":"STAT3 ChIP/reporter assays, RNA-IP of Mapkbp1 mRNA, translation assays, JNK pathway activity measurement in METTL8 KO/OE cells","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA-binding shown by RNA-IP, functional JNK pathway readout in KO cells, single lab","pmids":["29706498"],"is_preprint":false},{"year":2023,"finding":"Mettl8 is localized in mitochondria of mouse embryonic cortical neural stem cells and installs m3C specifically on mitochondrial tRNAThr/Ser(UCN). Conditional Mettl8 deletion reduces mitochondrial protein translation and respiration activity, leading to impaired embryonic cortical neural stem cell maintenance in vivo. Pharmacological enhancement of mitochondrial function rescues the neural stem cell maintenance defect caused by Mettl8 loss.","method":"Conditional knockout in mice, mitochondrial protein translation assays, respiration measurement, neural stem cell quantification in vivo, pharmacological rescue, human forebrain cortical organoids","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO in mice with in vivo cellular phenotype, pharmacological rescue, validated in human organoids, multiple orthogonal methods","pmids":["36764294"],"is_preprint":false},{"year":2021,"finding":"METTL8 expression is regulated by transcription factor YY1 in breast cancer cells. METTL8 protein directly binds ARID1A mRNA, and METTL8 knockdown increases ARID1A protein levels without changing ARID1A mRNA levels (suggesting translational repression). METTL8 knockdown strongly blocks tumor cell migration.","method":"YY1 knockdown with METTL8 expression measurement, RNA-IP of ARID1A mRNA, METTL8 knockdown with ARID1A protein/mRNA quantification, cell migration assays","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — RNA-binding by pulldown, protein vs. mRNA level dissociation supporting translational repression, single lab with two orthogonal methods","pmids":["34063990"],"is_preprint":false},{"year":2024,"finding":"In glioblastoma stem cells (GSCs), METTL8 is exclusively localized to the mitochondrial matrix where it installs m3C on mt-tRNAThr/Ser(UCN) for mitochondrial translation and respiration. METTL8 depletion decreases HIF1α protein levels, which reduces transcription of RTK genes and inactivates the RTK/Akt signaling axis. High METTL8 expression in GBM is attributed to histone variant H2AZ-mediated chromatin accessibility of HIF1α.","method":"Subcellular fractionation, m3C detection, METTL8 KD with HIF1α/RTK/Akt pathway analysis, intracranial xenograft model, chromatin accessibility assay (H2AZ)","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD with multiple downstream readouts, in vivo xenograft, mechanistic pathway placement, single lab","pmids":["38744809"],"is_preprint":false},{"year":2025,"finding":"Mettl8 stabilizes Tcf7 mRNA via m3C modification, enhancing Tcf1 protein expression in CD8+ TPEX cells. Additionally, Mettl8 interacts with Tcf1 protein to facilitate chromatin looping at the Tox locus, maintaining TPEX stemness. Mettl8 deletion drives TPEX differentiation into effective Int-TEX cells and restrains tumor progression.","method":"Mettl8 deletion in murine models, m3C modification of Tcf7 mRNA, Co-IP of Mettl8-Tcf1, chromatin conformation assay at Tox locus, T cell subset analysis, pharmacological inhibition","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with defined cellular phenotype, Co-IP, chromatin looping assay, single lab","pmids":["41891923"],"is_preprint":false},{"year":2026,"finding":"Mettl8 negatively regulates the Akt/mTOR/4E-BP1 pathway in hippocampal neural stem cells. Mettl8 knockdown activates this pathway (increased mTOR/4E-BP1 phosphorylation), induces G0/G1 arrest, and promotes neuronal and astrocytic differentiation markers. Rapamycin (mTOR inhibitor) reverses the enhanced mTOR/4E-BP1 phosphorylation and neuronal differentiation caused by Mettl8 loss.","method":"Lentiviral KD/OE in NSCs, EdU proliferation assay, flow cytometry cell cycle analysis, RNA-seq, Western blot of mTOR/4E-BP1 phosphorylation, rapamycin rescue","journal":"CNS neuroscience & therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD/OE with pharmacological rescue, multiple readouts, single lab","pmids":["42178900"],"is_preprint":false},{"year":2025,"finding":"METTL8 catalyzes m3C modification on mitochondrial mRNAs (mt-mRNAs), particularly those encoding complex I subunits, in addition to its known mt-tRNA activity. METTL8 depletion impairs cell migration in vitro and reduces tumor growth in mouse xenografts.","method":"Transcriptome-wide m3C mapping, METTL8 depletion with mt-mRNA m3C quantification, cell migration assays, mouse xenograft tumor growth assays","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 2 / Weak — preprint, single lab, novel substrate claim (mt-mRNA) not yet peer-reviewed or replicated","pmids":["bio_10.1101_2025.01.15.633161"],"is_preprint":true},{"year":2022,"finding":"miR-208b directly targets and inhibits Mettl8 expression (confirmed by dual luciferase assay). Mettl8 knockdown in C2C12 cells increases Myh7 (slow-twitch) and decreases Myh4 (fast-twitch) expression, indicating Mettl8 promotes fast muscle fiber formation. Mettl8 knockout in mice inhibits formation of fast muscle fibers.","method":"Dual luciferase assay confirming miR-208b targeting of Mettl8 3'UTR, siRNA knockdown of Mettl8 in C2C12 cells with myosin heavy chain isoform analysis, Mettl8 knockout mice","journal":"Frontiers in genetics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, luciferase assay plus KD phenotype, no molecular mechanism linking Mettl8 to myosin regulation","pmids":["35281804"],"is_preprint":false}],"current_model":"METTL8 is an RNA methyltransferase that exists as alternatively spliced isoforms: the mitochondria-targeted isoform (Iso1) installs m3C at position 32 of mt-tRNAThr and mt-tRNASer(UCN) using U34G35 and t6A37/(ms2)i6A37 as key substrate recognition elements, interacts with and stimulates mitochondrial aminoacyl-tRNA synthetases SARS2 and TARS2, and thereby optimizes mitoribosome translation of respiratory chain subunits, which is required for maintaining mitochondrial respiration, neural stem cell homeostasis, and various cancer cell states; while a nucleolar isoform (Iso4) lacking the catalytically critical N-terminal extension is inactive for m3C but may participate in R-loop regulation; additionally, METTL8 can modify mRNAs (including Tcf7 and ARID1A) via m3C to regulate their translation, and in some contexts acts downstream of STAT3 to suppress JNK signaling."},"narrative":{"mechanistic_narrative":"METTL8 is an RNA methyltransferase whose principal characterized activity is the installation of 3-methylcytidine (m3C) at position 32 of mitochondrial tRNAThr and tRNASer(UCN), a modification required for efficient mitochondrial translation and respiratory chain function [PMID:34774131, PMID:35247384]. The enzyme is expressed as alternatively spliced isoforms: the mitochondria-targeted Iso1, imported via an N-terminal presequence, carries the catalytic activity, whereas the nucleolar Iso4 lacks the N-terminal extension bearing absolutely conserved modification-critical residues and is inactive for m3C [PMID:35357504, PMID:37573249]. Target selection is achieved by crosslinking across the anticodon stem-loop of many mt-tRNAs, but methylation is restricted to substrates bearing the U34G35 plus t6A37/(ms2)i6A37 combination found only in mt-tRNAThr and mt-tRNASer(UCN) [PMID:35017528]. Beyond catalysis, Iso1 physically interacts with the mitochondrial aminoacyl-tRNA synthetases SARS2 and TARS2 in an RNA-independent manner and stimulates their aminoacylation activity, coupling m3C deposition to charging of its own substrate tRNAs [PMID:35357504, PMID:37573249]. Loss of METTL8 produces ribosome stalling on cognate codons and reduced incorporation of complex I subunits, lowering respiration [PMID:34774131, PMID:35017528]. This mitochondrial function underlies physiological roles in embryonic cortical neural stem cell maintenance, where conditional deletion impairs mitochondrial translation and respiration and is rescued by pharmacological enhancement of mitochondrial function [PMID:36764294], and in cancer cell states including glioblastoma stem cells, where METTL8 supports the HIF1α–RTK/Akt axis [PMID:38744809]. Additional reported activities include m3C-dependent regulation of specific mRNAs to control their translation or stability (ARID1A, Tcf7) and chromatin-associated functions [PMID:34063990, PMID:41891923], and an earlier-described nuclear RNA-binding complex involved in R-loop stabilization [PMID:32199293].","teleology":[{"year":2018,"claim":"Before any catalytic role was known, METTL8 was placed in a transcriptional and translational regulatory circuit, establishing that it can repress translation of a specific mRNA to influence stem cell fate.","evidence":"STAT3 ChIP/reporter, RNA-IP of Mapkbp1 mRNA, and JNK pathway readout in mouse ESC KO/OE cells","pmids":["29706498"],"confidence":"Medium","gaps":["No demonstration of m3C or methyltransferase activity in this context","Mechanism linking METTL8 binding to translational repression of Mapkbp1 not resolved","Single-lab study"]},{"year":2020,"claim":"An initial biochemical characterization assigned METTL8 to a large nuclear RNA-binding complex and linked its methyltransferase activity to R-loop stabilization, raising the question of a chromatin-associated role.","evidence":"Biochemical fractionation, pulldown, and R-loop quantification after knockout","pmids":["32199293"],"confidence":"Medium","gaps":["Relationship to the later-defined mitochondrial isoform unclear","Identity of complex members and direct RNA targets not fully resolved","m3C-dependence of R-loop effect not mapped to specific sites"]},{"year":2021,"claim":"The core enzymatic function was defined: METTL8 is a mitochondrial enzyme installing m3C32 on mt-tRNAThr and mt-tRNASer(UCN), connecting the modification to respiratory chain translation.","evidence":"KO/OE cell lines, mitoribosome profiling, mass spectrometry of respiratory complexes, m3C detection","pmids":["34774131"],"confidence":"High","gaps":["Substrate recognition determinants not yet defined","Isoform basis of mitochondrial targeting not established at this stage"]},{"year":2022,"claim":"The isoform logic, substrate-recognition code, and synthetase coupling were resolved, explaining how METTL8 achieves target specificity and is functionally integrated with tRNA charging.","evidence":"Alternative splicing/localization analysis, in vitro methylation with tRNA mutagenesis, crosslinking to mt-tRNA ASLs, native gel and aminoacylation assays, Co-IP with SARS2","pmids":["35357504","35247384","35017528"],"confidence":"High","gaps":["Functional consequence of SARS2 interaction is modest and incompletely defined","How m3C32 alters tRNA folding mechanistically not fully resolved","Reason m3C-deficient tRNAs still aminoacylate and bind ribosomes yet impair translation unclear"]},{"year":2023,"claim":"The catalytic determinants and an in vivo physiological role were established: the N-terminal extension carries the modification-critical residues, METTL8 stimulates both SARS2 and TARS2 aminoacylation, and its mitochondrial activity is required for cortical neural stem cell maintenance.","evidence":"In vitro m3C assays with N-extension mutagenesis, aminoacylation assays with SARS2/TARS2, conditional KO mice with respiration and NSC quantification, pharmacological rescue, human organoids","pmids":["37573249","36764294"],"confidence":"High","gaps":["Mechanism by which reduced mitochondrial translation impairs NSC maintenance not fully delineated","Whether non-mitochondrial activities contribute to the phenotype untested"]},{"year":2024,"claim":"METTL8's mitochondrial activity was tied to oncogenic signaling, placing it upstream of HIF1α and the RTK/Akt axis in glioblastoma stem cells.","evidence":"Subcellular fractionation, m3C detection, knockdown with HIF1α/RTK/Akt analysis, intracranial xenografts, H2AZ chromatin accessibility assay","pmids":["38744809"],"confidence":"Medium","gaps":["Causal chain from mitochondrial translation to HIF1α protein levels not mechanistically dissected","Single-lab finding"]},{"year":2025,"claim":"Reported substrate scope expanded toward specific mRNAs, with m3C-dependent control of Tcf7 mRNA stability and a Tcf1-interaction-driven chromatin function maintaining T cell stemness, plus a preprint claim of mt-mRNA modification.","evidence":"Murine Mettl8 deletion, m3C modification of Tcf7 mRNA, Co-IP with Tcf1, chromatin looping at Tox; transcriptome-wide m3C mapping of mt-mRNAs (preprint)","pmids":["41891923","bio_10.1101_2025.01.15.633161"],"confidence":"Medium","gaps":["mRNA m3C substrate claims rest largely on single labs and a preprint","Direct catalysis vs indirect effects on these mRNAs not fully separated from the mitochondrial role","mt-mRNA modification not peer-reviewed or replicated"]},{"year":2026,"claim":"A further signaling link was reported, with METTL8 negatively regulating the Akt/mTOR/4E-BP1 pathway to restrain neural stem cell differentiation.","evidence":"KD/OE in hippocampal NSCs, proliferation and cell-cycle assays, RNA-seq, phospho-Western, rapamycin rescue","pmids":["42178900"],"confidence":"Medium","gaps":["Molecular connection between METTL8 catalytic activity and mTOR pathway control not defined","Whether effect is mitochondrial or mRNA-mediated unresolved"]},{"year":null,"claim":"It remains unresolved how METTL8's non-tRNA activities (mRNA m3C, R-loop regulation, chromatin/Tcf1 functions) mechanistically relate to its mitochondrial catalytic role, and whether they represent isoform-specific or moonlighting functions.","evidence":"","pmids":[],"confidence":"Low","gaps":["No unified model integrating mitochondrial vs nuclear/cytoplasmic activities","Direct mRNA substrates and their methylation sites not comprehensively validated","No human disease linkage established in the corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,2,3,4]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[0,1,3,4]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[3,5,8,10]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,1,2,7,9]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[1,4]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,1,3,4]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,3,7]}],"complexes":[],"partners":["SARS2","TARS2","TCF7"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H825","full_name":"tRNA N(3)-cytidine methyltransferase METTL8, mitochondrial","aliases":["Methyltransferase-like protein 8","mRNA N(3)-methylcytidine methyltransferase METTL8"],"length_aa":291,"mass_kda":33.4,"function":"Mitochondrial S-adenosyl-L-methionine-dependent methyltransferase that mediates N(3)-methylcytidine modification of residue 32 of the tRNA anticodon loop of mitochondrial tRNA(Ser)(UCN) and tRNA(Thr) (PubMed:34774131, PubMed:35017528). N(3)-methylcytidine methylation modification regulates mitochondrial translation efficiency and is required for activity of the respiratory chain (PubMed:34774131, PubMed:35017528). N(3)-methylcytidine methylation of mitochondrial tRNA(Ser)(UCN) requires the formation of N(6)-dimethylallyladenosine(37) (i6A37) by TRIT1 as prerequisite (PubMed:34774131, PubMed:35017528). May also mediate N(3)-methylcytidine modification of mRNAs (PubMed:28655767). The existence of N(3)-methylcytidine modification on mRNAs is however unclear, and additional evidences are required to confirm the role of the N(3)-methylcytidine-specific mRNA methyltransferase activity of METTL8 in vivo (PubMed:33313824, PubMed:34774131)","subcellular_location":"Mitochondrion","url":"https://www.uniprot.org/uniprotkb/Q9H825/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/METTL8","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1090,"dependency_fraction":0.0027522935779816515},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/METTL8","total_profiled":1310},"omim":[{"mim_id":"609525","title":"METHYLTRANSFERASE 8, METHYLCYTIDINE; METTL8","url":"https://www.omim.org/entry/609525"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/METTL8"},"hgnc":{"alias_symbol":["FLJ13984","TIP"],"prev_symbol":[]},"alphafold":{"accession":"Q9H825","domains":[{"cath_id":"3.40.50","chopping":"54-116_193-291","consensus_level":"medium","plddt":93.6317,"start":54,"end":291}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H825","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H825-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H825-F1-predicted_aligned_error_v6.png","plddt_mean":73.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=METTL8","jax_strain_url":"https://www.jax.org/strain/search?query=METTL8"},"sequence":{"accession":"Q9H825","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H825.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H825/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H825"}},"corpus_meta":[{"pmid":"34774131","id":"PMC_34774131","title":"Balancing of mitochondrial translation through METTL8-mediated m3C modification of mitochondrial tRNAs.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/34774131","citation_count":73,"is_preprint":false},{"pmid":"32199293","id":"PMC_32199293","title":"The SUMOylated METTL8 Induces R-loop and Tumorigenesis via m3C.","date":"2020","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/32199293","citation_count":52,"is_preprint":false},{"pmid":"28803425","id":"PMC_28803425","title":"Frameshift Mutations in Repeat Sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 Genes in Colon Cancers.","date":"2017","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/28803425","citation_count":47,"is_preprint":false},{"pmid":"35017528","id":"PMC_35017528","title":"The RNA methyltransferase METTL8 installs m3C32 in mitochondrial tRNAsThr/Ser(UCN) to optimise tRNA structure and mitochondrial translation.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35017528","citation_count":44,"is_preprint":false},{"pmid":"36764294","id":"PMC_36764294","title":"Epitranscriptomic regulation of cortical neurogenesis via Mettl8-dependent mitochondrial tRNA m3C modification.","date":"2023","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/36764294","citation_count":37,"is_preprint":false},{"pmid":"35357504","id":"PMC_35357504","title":"Molecular basis for human mitochondrial tRNA m3C modification by alternatively spliced METTL8.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/35357504","citation_count":35,"is_preprint":false},{"pmid":"35247384","id":"PMC_35247384","title":"Methyltransferase METTL8 is required for 3-methylcytosine modification in human mitochondrial tRNAs.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35247384","citation_count":27,"is_preprint":false},{"pmid":"29706498","id":"PMC_29706498","title":"The STAT3 Target Mettl8 Regulates Mouse ESC Differentiation via Inhibiting the JNK Pathway.","date":"2018","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29706498","citation_count":15,"is_preprint":false},{"pmid":"35281804","id":"PMC_35281804","title":"MiR-208b Regulates the Conversion of Skeletal Muscle Fiber Types by Inhibiting Mettl8 Expression.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35281804","citation_count":15,"is_preprint":false},{"pmid":"34063990","id":"PMC_34063990","title":"METTL8 mRNA Methyltransferase Enhances Cancer Cell Migration via Direct Binding to ARID1A.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34063990","citation_count":14,"is_preprint":false},{"pmid":"37573249","id":"PMC_37573249","title":"Mitochondrial RNA m3C methyltransferase METTL8 relies on an isoform-specific N-terminal extension and modifies multiple heterogenous tRNAs.","date":"2023","source":"Science bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/37573249","citation_count":14,"is_preprint":false},{"pmid":"38744809","id":"PMC_38744809","title":"METTL8 links mt-tRNA m3C modification to the HIF1α/RTK/Akt axis to sustain GBM stemness and tumorigenicity.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38744809","citation_count":12,"is_preprint":false},{"pmid":"34861186","id":"PMC_34861186","title":"METTLing in the right place: METTL8 is a mitochondrial tRNA-specific methyltransferase.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/34861186","citation_count":8,"is_preprint":false},{"pmid":"39701355","id":"PMC_39701355","title":"Targeting METTL8 with Rabdosiin overcomes lenvatinib resistance in hepatocellular carcinoma.","date":"2024","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/39701355","citation_count":4,"is_preprint":false},{"pmid":"41891923","id":"PMC_41891923","title":"Targeting Mettl8-Tcf1 axis promotes CD8+ TPEX differentiation and antitumor immunity.","date":"2026","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41891923","citation_count":1,"is_preprint":false},{"pmid":"42178900","id":"PMC_42178900","title":"Mettl8 Regulates Hippocampal Neural Stem Cell Proliferation and Neurogenesis via mTOR/4E-BP1 Signaling.","date":"2026","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/42178900","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.01.15.633161","title":"m  <sup>3</sup>  C is a mitochondrial mRNA modification which promotes tumor progression","date":"2025-01-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.15.633161","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10465,"output_tokens":4262,"usd":0.047662,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12051,"output_tokens":3557,"usd":0.07459,"stage2_stop_reason":"end_turn"},"total_usd":0.122252,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2021,\n      \"finding\": \"METTL8 is a mitochondrial protein that installs 3-methylcytidine (m3C) at position C32 of mt-tRNASer(UCN) and mt-tRNAThr. METTL8 knockout reduces respiratory chain activity while overexpression increases it. Mitoribosome profiling revealed stalling on mt-tRNASer(UCN)- and mt-tRNAThr-dependent codons in knockout cells, and mass spectrometry showed reduced incorporation of ND6 and ND1 into complex I.\",\n      \"method\": \"Knockout/overexpression cell lines, mitochondrial ribosome profiling, mass spectrometry of respiratory chain complexes, m3C detection\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (ribosome profiling, MS, KO/OE phenotypes), replicated across multiple subsequent studies\",\n      \"pmids\": [\"34774131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL8 exists as alternatively spliced isoforms: METTL8-Iso1 is targeted to mitochondria via an N-terminal pre-sequence and catalyzes m3C32 on mt-tRNAThr and mt-tRNASer(UCN), while METTL8-Iso4 localizes to the nucleolus. Substrate specificity of Iso1 for mt-tRNAThr requires G35 but not t6A37, while mt-tRNASer(UCN) modification critically depends on i6A37. METTL8-Iso1 interacts with mitochondrial seryl-tRNA synthetase (SARS2) in an RNA-independent manner, which modestly accelerates m3C modification activity.\",\n      \"method\": \"Alternative splicing analysis, subcellular fractionation/localization, in vitro methylation assays, mutagenesis of tRNA recognition elements, Co-IP\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis, isoform localization experiments, RNA-independent Co-IP, replicated by multiple labs\",\n      \"pmids\": [\"35357504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL8 is a mitochondria-associated protein required for m3C formation in human mt-tRNA-Ser-UGA and mt-tRNA-Thr-UGU but not nuclear-encoded tRNAs. METTL8 interacts with mitochondrial seryl-tRNA synthetase and mt-tRNAs. Re-expression of WT METTL8 rescues m3C loss, but a variant lacking the N-terminal mitochondrial localization signal does not. Loss of METTL8 alters native migration pattern of mt-tRNA-Ser-UGA, suggesting m3C influences tRNA folding.\",\n      \"method\": \"METTL8-deficient human cells, m3C detection by sequencing, Co-IP with mitochondrial seryl-tRNA synthetase, rescue with MLS-deletion variant, native gel analysis of tRNA migration\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (KO rescue, Co-IP, tRNA migration assay), consistent with replicated findings across labs\",\n      \"pmids\": [\"35247384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL8 crosslinks to the anticodon stem loop (ASL) of many mt-tRNAs, but methylation target specificity is determined by U34G35 combined with t6A37/(ms2)i6A37, present only in mt-tRNAThr and mt-tRNASer(UCN). m3C32 modification influences the structure of these mt-tRNAs, though mt-tRNAs lacking m3C32 are still efficiently aminoacylated and associate with mitochondrial ribosomes. Mitochondrial translation is mildly impaired without METTL8.\",\n      \"method\": \"METTL8 crosslinking to mt-tRNAs, dissection of tRNA recognition elements by mutagenesis, structural probing of mt-tRNAs, aminoacylation assays, mitoribosome association assays, translation assays in METTL8 KO cells\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods including crosslinking, in vitro mutagenesis of recognition elements, structural and functional assays\",\n      \"pmids\": [\"35017528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mettl8-Iso4 (nucleolar isoform) is catalytically inactive for m3C32 generation due to lack of the N-terminal extension (N-extension), which contains absolutely conserved modification-critical residues. These residues are also essential for cytoplasmic m3C32 by METTL2A and yeast Trm140. METTL8-Iso1 can modify several cytoplasmic or bacterial tRNAs in vitro. METTL8-Iso1 also interacts with mitochondrial threonyl-tRNA synthetase (TARS2) in addition to SARS2, and substantially stimulates aminoacylation activities of both SARS2 and TARS2 in vitro.\",\n      \"method\": \"In vitro m3C32 methylation assays with Iso1 and Iso4, mutagenesis of N-extension residues, cross-species tRNA modification assays, Co-IP with TARS2, aminoacylation activity assays\",\n      \"journal\": \"Science bulletin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis, cross-species tRNA assays, aminoacylation functional assays\",\n      \"pmids\": [\"37573249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"METTL8 forms a large SUMOylated nuclear RNA-binding protein complex (~0.8 megadaltons) containing R-loop-related factors in the nucleus. Genetic ablation of METTL8 results in overall reduction of R-loops in cells. METTL8 binds to RNAs and stabilizes R-loops on selected gene regions through its methyltransferase activity on m3C.\",\n      \"method\": \"Biochemical fractionation, pulldown/interaction assays, R-loop quantification after METTL8 knockout, RNA-binding assays\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and genetic KO with R-loop readout, single lab, two orthogonal methods\",\n      \"pmids\": [\"32199293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"METTL8 is a STAT3 transcriptional target in mouse ESCs. METTL8 interacts with Mapkbp1 mRNA (an intermediate in JNK signaling) and inhibits translation of that mRNA, thereby suppressing JNK pathway activation and enhancing ESC differentiation.\",\n      \"method\": \"STAT3 ChIP/reporter assays, RNA-IP of Mapkbp1 mRNA, translation assays, JNK pathway activity measurement in METTL8 KO/OE cells\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA-binding shown by RNA-IP, functional JNK pathway readout in KO cells, single lab\",\n      \"pmids\": [\"29706498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mettl8 is localized in mitochondria of mouse embryonic cortical neural stem cells and installs m3C specifically on mitochondrial tRNAThr/Ser(UCN). Conditional Mettl8 deletion reduces mitochondrial protein translation and respiration activity, leading to impaired embryonic cortical neural stem cell maintenance in vivo. Pharmacological enhancement of mitochondrial function rescues the neural stem cell maintenance defect caused by Mettl8 loss.\",\n      \"method\": \"Conditional knockout in mice, mitochondrial protein translation assays, respiration measurement, neural stem cell quantification in vivo, pharmacological rescue, human forebrain cortical organoids\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO in mice with in vivo cellular phenotype, pharmacological rescue, validated in human organoids, multiple orthogonal methods\",\n      \"pmids\": [\"36764294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"METTL8 expression is regulated by transcription factor YY1 in breast cancer cells. METTL8 protein directly binds ARID1A mRNA, and METTL8 knockdown increases ARID1A protein levels without changing ARID1A mRNA levels (suggesting translational repression). METTL8 knockdown strongly blocks tumor cell migration.\",\n      \"method\": \"YY1 knockdown with METTL8 expression measurement, RNA-IP of ARID1A mRNA, METTL8 knockdown with ARID1A protein/mRNA quantification, cell migration assays\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — RNA-binding by pulldown, protein vs. mRNA level dissociation supporting translational repression, single lab with two orthogonal methods\",\n      \"pmids\": [\"34063990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In glioblastoma stem cells (GSCs), METTL8 is exclusively localized to the mitochondrial matrix where it installs m3C on mt-tRNAThr/Ser(UCN) for mitochondrial translation and respiration. METTL8 depletion decreases HIF1α protein levels, which reduces transcription of RTK genes and inactivates the RTK/Akt signaling axis. High METTL8 expression in GBM is attributed to histone variant H2AZ-mediated chromatin accessibility of HIF1α.\",\n      \"method\": \"Subcellular fractionation, m3C detection, METTL8 KD with HIF1α/RTK/Akt pathway analysis, intracranial xenograft model, chromatin accessibility assay (H2AZ)\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD with multiple downstream readouts, in vivo xenograft, mechanistic pathway placement, single lab\",\n      \"pmids\": [\"38744809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Mettl8 stabilizes Tcf7 mRNA via m3C modification, enhancing Tcf1 protein expression in CD8+ TPEX cells. Additionally, Mettl8 interacts with Tcf1 protein to facilitate chromatin looping at the Tox locus, maintaining TPEX stemness. Mettl8 deletion drives TPEX differentiation into effective Int-TEX cells and restrains tumor progression.\",\n      \"method\": \"Mettl8 deletion in murine models, m3C modification of Tcf7 mRNA, Co-IP of Mettl8-Tcf1, chromatin conformation assay at Tox locus, T cell subset analysis, pharmacological inhibition\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with defined cellular phenotype, Co-IP, chromatin looping assay, single lab\",\n      \"pmids\": [\"41891923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Mettl8 negatively regulates the Akt/mTOR/4E-BP1 pathway in hippocampal neural stem cells. Mettl8 knockdown activates this pathway (increased mTOR/4E-BP1 phosphorylation), induces G0/G1 arrest, and promotes neuronal and astrocytic differentiation markers. Rapamycin (mTOR inhibitor) reverses the enhanced mTOR/4E-BP1 phosphorylation and neuronal differentiation caused by Mettl8 loss.\",\n      \"method\": \"Lentiviral KD/OE in NSCs, EdU proliferation assay, flow cytometry cell cycle analysis, RNA-seq, Western blot of mTOR/4E-BP1 phosphorylation, rapamycin rescue\",\n      \"journal\": \"CNS neuroscience & therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD/OE with pharmacological rescue, multiple readouts, single lab\",\n      \"pmids\": [\"42178900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"METTL8 catalyzes m3C modification on mitochondrial mRNAs (mt-mRNAs), particularly those encoding complex I subunits, in addition to its known mt-tRNA activity. METTL8 depletion impairs cell migration in vitro and reduces tumor growth in mouse xenografts.\",\n      \"method\": \"Transcriptome-wide m3C mapping, METTL8 depletion with mt-mRNA m3C quantification, cell migration assays, mouse xenograft tumor growth assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 2 / Weak — preprint, single lab, novel substrate claim (mt-mRNA) not yet peer-reviewed or replicated\",\n      \"pmids\": [\"bio_10.1101_2025.01.15.633161\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"miR-208b directly targets and inhibits Mettl8 expression (confirmed by dual luciferase assay). Mettl8 knockdown in C2C12 cells increases Myh7 (slow-twitch) and decreases Myh4 (fast-twitch) expression, indicating Mettl8 promotes fast muscle fiber formation. Mettl8 knockout in mice inhibits formation of fast muscle fibers.\",\n      \"method\": \"Dual luciferase assay confirming miR-208b targeting of Mettl8 3'UTR, siRNA knockdown of Mettl8 in C2C12 cells with myosin heavy chain isoform analysis, Mettl8 knockout mice\",\n      \"journal\": \"Frontiers in genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, luciferase assay plus KD phenotype, no molecular mechanism linking Mettl8 to myosin regulation\",\n      \"pmids\": [\"35281804\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"METTL8 is an RNA methyltransferase that exists as alternatively spliced isoforms: the mitochondria-targeted isoform (Iso1) installs m3C at position 32 of mt-tRNAThr and mt-tRNASer(UCN) using U34G35 and t6A37/(ms2)i6A37 as key substrate recognition elements, interacts with and stimulates mitochondrial aminoacyl-tRNA synthetases SARS2 and TARS2, and thereby optimizes mitoribosome translation of respiratory chain subunits, which is required for maintaining mitochondrial respiration, neural stem cell homeostasis, and various cancer cell states; while a nucleolar isoform (Iso4) lacking the catalytically critical N-terminal extension is inactive for m3C but may participate in R-loop regulation; additionally, METTL8 can modify mRNAs (including Tcf7 and ARID1A) via m3C to regulate their translation, and in some contexts acts downstream of STAT3 to suppress JNK signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"METTL8 is an RNA methyltransferase whose principal characterized activity is the installation of 3-methylcytidine (m3C) at position 32 of mitochondrial tRNAThr and tRNASer(UCN), a modification required for efficient mitochondrial translation and respiratory chain function [#0, #2]. The enzyme is expressed as alternatively spliced isoforms: the mitochondria-targeted Iso1, imported via an N-terminal presequence, carries the catalytic activity, whereas the nucleolar Iso4 lacks the N-terminal extension bearing absolutely conserved modification-critical residues and is inactive for m3C [#1, #4]. Target selection is achieved by crosslinking across the anticodon stem-loop of many mt-tRNAs, but methylation is restricted to substrates bearing the U34G35 plus t6A37/(ms2)i6A37 combination found only in mt-tRNAThr and mt-tRNASer(UCN) [#3]. Beyond catalysis, Iso1 physically interacts with the mitochondrial aminoacyl-tRNA synthetases SARS2 and TARS2 in an RNA-independent manner and stimulates their aminoacylation activity, coupling m3C deposition to charging of its own substrate tRNAs [#1, #4]. Loss of METTL8 produces ribosome stalling on cognate codons and reduced incorporation of complex I subunits, lowering respiration [#0, #3]. This mitochondrial function underlies physiological roles in embryonic cortical neural stem cell maintenance, where conditional deletion impairs mitochondrial translation and respiration and is rescued by pharmacological enhancement of mitochondrial function [#7], and in cancer cell states including glioblastoma stem cells, where METTL8 supports the HIF1\\u03b1\\u2013RTK/Akt axis [#9]. Additional reported activities include m3C-dependent regulation of specific mRNAs to control their translation or stability (ARID1A, Tcf7) and chromatin-associated functions [#8, #10], and an earlier-described nuclear RNA-binding complex involved in R-loop stabilization [#5].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 2018,\n      \"claim\": \"Before any catalytic role was known, METTL8 was placed in a transcriptional and translational regulatory circuit, establishing that it can repress translation of a specific mRNA to influence stem cell fate.\",\n      \"evidence\": \"STAT3 ChIP/reporter, RNA-IP of Mapkbp1 mRNA, and JNK pathway readout in mouse ESC KO/OE cells\",\n      \"pmids\": [\"29706498\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No demonstration of m3C or methyltransferase activity in this context\", \"Mechanism linking METTL8 binding to translational repression of Mapkbp1 not resolved\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"An initial biochemical characterization assigned METTL8 to a large nuclear RNA-binding complex and linked its methyltransferase activity to R-loop stabilization, raising the question of a chromatin-associated role.\",\n      \"evidence\": \"Biochemical fractionation, pulldown, and R-loop quantification after knockout\",\n      \"pmids\": [\"32199293\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relationship to the later-defined mitochondrial isoform unclear\", \"Identity of complex members and direct RNA targets not fully resolved\", \"m3C-dependence of R-loop effect not mapped to specific sites\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The core enzymatic function was defined: METTL8 is a mitochondrial enzyme installing m3C32 on mt-tRNAThr and mt-tRNASer(UCN), connecting the modification to respiratory chain translation.\",\n      \"evidence\": \"KO/OE cell lines, mitoribosome profiling, mass spectrometry of respiratory complexes, m3C detection\",\n      \"pmids\": [\"34774131\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate recognition determinants not yet defined\", \"Isoform basis of mitochondrial targeting not established at this stage\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"The isoform logic, substrate-recognition code, and synthetase coupling were resolved, explaining how METTL8 achieves target specificity and is functionally integrated with tRNA charging.\",\n      \"evidence\": \"Alternative splicing/localization analysis, in vitro methylation with tRNA mutagenesis, crosslinking to mt-tRNA ASLs, native gel and aminoacylation assays, Co-IP with SARS2\",\n      \"pmids\": [\"35357504\", \"35247384\", \"35017528\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of SARS2 interaction is modest and incompletely defined\", \"How m3C32 alters tRNA folding mechanistically not fully resolved\", \"Reason m3C-deficient tRNAs still aminoacylate and bind ribosomes yet impair translation unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The catalytic determinants and an in vivo physiological role were established: the N-terminal extension carries the modification-critical residues, METTL8 stimulates both SARS2 and TARS2 aminoacylation, and its mitochondrial activity is required for cortical neural stem cell maintenance.\",\n      \"evidence\": \"In vitro m3C assays with N-extension mutagenesis, aminoacylation assays with SARS2/TARS2, conditional KO mice with respiration and NSC quantification, pharmacological rescue, human organoids\",\n      \"pmids\": [\"37573249\", \"36764294\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which reduced mitochondrial translation impairs NSC maintenance not fully delineated\", \"Whether non-mitochondrial activities contribute to the phenotype untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"METTL8's mitochondrial activity was tied to oncogenic signaling, placing it upstream of HIF1\\u03b1 and the RTK/Akt axis in glioblastoma stem cells.\",\n      \"evidence\": \"Subcellular fractionation, m3C detection, knockdown with HIF1\\u03b1/RTK/Akt analysis, intracranial xenografts, H2AZ chromatin accessibility assay\",\n      \"pmids\": [\"38744809\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal chain from mitochondrial translation to HIF1\\u03b1 protein levels not mechanistically dissected\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Reported substrate scope expanded toward specific mRNAs, with m3C-dependent control of Tcf7 mRNA stability and a Tcf1-interaction-driven chromatin function maintaining T cell stemness, plus a preprint claim of mt-mRNA modification.\",\n      \"evidence\": \"Murine Mettl8 deletion, m3C modification of Tcf7 mRNA, Co-IP with Tcf1, chromatin looping at Tox; transcriptome-wide m3C mapping of mt-mRNAs (preprint)\",\n      \"pmids\": [\"41891923\", \"bio_10.1101_2025.01.15.633161\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"mRNA m3C substrate claims rest largely on single labs and a preprint\", \"Direct catalysis vs indirect effects on these mRNAs not fully separated from the mitochondrial role\", \"mt-mRNA modification not peer-reviewed or replicated\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"A further signaling link was reported, with METTL8 negatively regulating the Akt/mTOR/4E-BP1 pathway to restrain neural stem cell differentiation.\",\n      \"evidence\": \"KD/OE in hippocampal NSCs, proliferation and cell-cycle assays, RNA-seq, phospho-Western, rapamycin rescue\",\n      \"pmids\": [\"42178900\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular connection between METTL8 catalytic activity and mTOR pathway control not defined\", \"Whether effect is mitochondrial or mRNA-mediated unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how METTL8's non-tRNA activities (mRNA m3C, R-loop regulation, chromatin/Tcf1 functions) mechanistically relate to its mitochondrial catalytic role, and whether they represent isoform-specific or moonlighting functions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified model integrating mitochondrial vs nuclear/cytoplasmic activities\", \"Direct mRNA substrates and their methylation sites not comprehensively validated\", \"No human disease linkage established in the corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 1, 3, 4]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [3, 5, 8, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 2, 7, 9]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 1, 3, 4]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 3, 7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"SARS2\", \"TARS2\", \"TCF7\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}